Latigo Biotherapeutics Inc.
NASDAQ:LTGOMedical - Pharmaceuticals
Healthcare
$13.31 +5.43%
+$0.76 today
- Market cap
- $800.64M
- Beta
- 0.00
52W Low $13.50High $25.93
Volume 0.21M
Average 0.38M
LTGO Total Current Liabilities
All obligations due within one year.
No reported Total Current Liabilities figures are available to summarize.
Total Current Liabilities history
Currency unavailable · from the balance sheet
No Total Current Liabilities data reported for this period type.
Total Current Liabilities vs competitors
How LTGO compares with its peers on the latest reported figures
LTGO Competitors
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $501.75M USD | +82.0% | +120.9% | 170.9% | |
| Mar 2026 | $434.97M USD | -10.6% | +0.5% | 26.3% | |
| Mar 2026 | $108.79M USD | -65.4% | -6.6% | 9.0% | |
LTGOLatigo Biotherapeutics Inc. | — | — | — | — | — |
| Peer median (excluding LTGO) | — | -10.6% | +0.5% | 26.3% | |
Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Currency unavailable
Latigo Biotherapeutics Inc.
NASDAQ:LTGO
Intrinsic Alpha fair value
Locked
Current Price
$13.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.